| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1
Edward Mallinckrodt Institute of Radiology, Washington University School of
Medicine, 510 S. Kingshighway Blvd., St. Louis, MO 63110.
2
Department of Pathology, Washington University School of Medicine, St. Louis,
MO 63110.
OBJECTIVE. Our goal was to assess the sensitivity of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) for the detection of mucinous carcinoma and to determine the histologic features of these tumors that may affect lesion detectability.
MATERIALS AND METHODS. A retrospective review of all patients with mucinous carcinoma who had undergone FDG PET at our institution from 1995 through 1998 identified 25 patients with new or recurrent mucinous carcinoma at the time of PET. In 22 of these patients, tissue specimens available from either core biopsy or surgical resection allowed detailed histologic analysis.
RESULTS. FDG PET revealed mucinous carcinoma in only 13 (59%) of 22 patients, resulting in an unusually high percentage (41%) of false-negative results. Two histologic features were found to be predictive of FDG PET results: tumor cellularity (p = 0.011) and the amount of mucin within the tumor mass (p = 0.009). There was a positive correlation between tumor FDG uptake and cellularity but a negative correlation with the amount of mucin.
CONCLUSION. FDG PET is limited in the evaluation of mucinous tumors, particularly in hypocellular lesions with abundant mucin.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Belcher, A. G. Nicholson, D. M. Hansell, and P. Goldstraw Imaging characteristics of a mucinous colorectal pulmonary metastasis. Ann. Thorac. Surg., November 1, 2008; 86(5): 1698 - 1698. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Goudarzi, H. A. Jacene, and R. L. Wahl Diagnosis and Differentiation of Bronchioloalveolar Carcinoma from Adenocarcinoma with Bronchioloalveolar Components with Metabolic and Anatomic Characteristics Using PET/CT J. Nucl. Med., October 1, 2008; 49(10): 1585 - 1592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Blodgett, C. C. Meltzer, and D. W. Townsend PET/CT: Form and Function Radiology, February 1, 2007; 242(2): 360 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Blake, A. Singh, B. N. Setty, J. Slattery, M. Kalra, M. M. Maher, D. V. Sahani, A. J. Fischman, and P. R. Mueller Pearls and Pitfalls in Interpretation of Abdominal and Pelvic PET-CT RadioGraphics, September 1, 2006; 26(5): 1335 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Khandani and R. C. Semelka Can the Relation between Gadopentetate Dimeglumine and FDG Uptake in Colorectal Liver Metastases Be Used Clinically? Radiology, October 1, 2005; 237(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
 |
|
 D. V. Sahani, S. P. Kalva, A. J. Fischman, R. Kadavigere, M. Blake, P. F. Hahn, and S. Saini Detection of Liver Metastases from Adenocarcinoma of the Colon and Pancreas: Comparison of Mangafodipir Trisodium-Enhanced Liver MRI and Whole-Body FDG PET Am. J. Roentgenol., July 1, 2005; 185(1): 239 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Cheran, N. D. Nielsen, and E. F. Patz Jr. False-Negative Findings for Primary Lung Tumors on FDG Positron Emission Tomography: Staging and Prognostic Implications Am. J. Roentgenol., May 1, 2004; 182(5): 1129 - 1132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Schoder, S. M. Larson, and H. W.D. Yeung PET/CT in Oncology: Integration into Clinical Management of Lymphoma, Melanoma, and Gastrointestinal Malignancies J. Nucl. Med., January 1, 2004; 45(90010): 72S - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cohade, M. Osman, J. Leal, and R. L. Wahl Direct Comparison of 18F-FDG PET and PET/CT in Patients with Colorectal Carcinoma J. Nucl. Med., November 1, 2003; 44(11): 1797 - 1803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A. Zealley, S. J. Skehan, J. Rawlinson, G. Coates, C. Nahmias, and S. Somers Selection of Patients for Resection of Hepatic Metastases: Improved Detection of Extrahepatic Disease with FDG PET RadioGraphics, October 1, 2001; 21(90001): S55 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nakamoto, T. Saga, T. Ishimori, M. Mamede, K. Togashi, T. Higuchi, M. Mandai, S. Fujii, H. Sakahara, and J. Konishi Clinical Value of Positron Emission Tomography with FDG for Recurrent Ovarian Cancer Am. J. Roentgenol., June 1, 2001; 176(6): 1449 - 1454. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
